144 related articles for article (PubMed ID: 31365665)
1. Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide.
Mello RB; Vale ECSD
An Bras Dermatol; 2019 Jul; 94(3):337-340. PubMed ID: 31365665
[TBL] [Abstract][Full Text] [Related]
2. Complete response to thalidomide and dexamethasone in a patient with necrobiotic xanthogranuloma associated with monoclonal gammopathy: a case report and review of the literature.
Efebera Y; Blanchard E; Allam C; Han A; Lee S; Munshi N
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11(3):298-302. PubMed ID: 21658660
[TBL] [Abstract][Full Text] [Related]
3. Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
[TBL] [Abstract][Full Text] [Related]
4. Necrobiotic xanthogranuloma of the extremities with paraproteinemia and without periorbital involvement at presentation.
Hashemi P; Rashidi A; Chapas AM; Balfour EM
Cutis; 2012 Jan; 89(1):41-4. PubMed ID: 22439311
[TBL] [Abstract][Full Text] [Related]
5. Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasone.
Dholaria BR; Cappel M; Roy V
Ann Hematol; 2016 Mar; 95(4):671-2. PubMed ID: 26814914
[No Abstract] [Full Text] [Related]
6. Necrobiotic xanthogranuloma.
Rose A; Robinson M; Kamino H; Latkowski JA
Dermatol Online J; 2012 Dec; 18(12):30. PubMed ID: 23286820
[TBL] [Abstract][Full Text] [Related]
7. Necrobiotic Xanthogranuloma.
Portuguese AJ; Long TH; Linenberger M
Mayo Clin Proc; 2021 Sep; 96(9):2432-2434. PubMed ID: 34481598
[No Abstract] [Full Text] [Related]
8. Periorbital necrobiotic xanthogranuloma treated successfully with novel multiple myeloma therapy.
Ghani S; Al Ustwani O; Khalid B; Bogner P; Grassi M; Powell J; Bhat SA
Clin Adv Hematol Oncol; 2013 Oct; 11(10):678-80. PubMed ID: 24518382
[No Abstract] [Full Text] [Related]
9. Necrobiotic xanthogranuloma as an unusual cause of refractive chronic bilateral leg ulceration.
Ghiasi N; Alavi A; Coutts PM; Ghazarian D; Sibbald RG
Int J Low Extrem Wounds; 2012 Dec; 11(4):293-5. PubMed ID: 23222162
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of necrobiotic xanthogranuloma with intravenous immunoglobulin.
Rubinstein A; Wolf DJ; Granstein RD
J Cutan Med Surg; 2013; 17(5):347-50. PubMed ID: 24067856
[TBL] [Abstract][Full Text] [Related]
11. Necrobiotic xanthogranuloma treated with lenalidomide.
Mahendran P; Wee J; Chong H; Natkunarajah J
Clin Exp Dermatol; 2018 Apr; 43(3):345-347. PubMed ID: 29048134
[No Abstract] [Full Text] [Related]
12. Thalidomide for necrobiotic xanthogranuloma.
Ali FR; Lear JT
Clin Exp Dermatol; 2022 Apr; 47(4):769-770. PubMed ID: 34856016
[No Abstract] [Full Text] [Related]
13. Treatment of necrobiotic xanthogranuloma - a systematic review.
Miguel D; Lukacs J; Illing T; Elsner P
J Eur Acad Dermatol Venereol; 2017 Feb; 31(2):221-235. PubMed ID: 27436448
[TBL] [Abstract][Full Text] [Related]
14. First case report of pre-mortem biopsy-proven kidney involvement by necrobiotic xanthogranuloma with monoclonal gammopathy.
Bleasel JM; Hopp JP; Cunningham I; Ritchie AG
J Nephrol; 2022 Jul; 35(6):1753-1757. PubMed ID: 34739712
[TBL] [Abstract][Full Text] [Related]
15. Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren syndrome.
Naghashpour M; Setoodeh R; Moscinski L; Bergier G; McCardle T; Glass F; Sokol L
Am J Dermatopathol; 2011 Dec; 33(8):855-7. PubMed ID: 22042261
[TBL] [Abstract][Full Text] [Related]
16. [Disseminated necrobiotic xanthogranuloma].
Klingner M; Hansel G; Schönlebe J; Wollina U
Hautarzt; 2016 Nov; 67(11):902-906. PubMed ID: 27380383
[TBL] [Abstract][Full Text] [Related]
17. Necrobiotic xanthogranuloma treated with a combination of oral methylprednisolone and cyclosporin.
Lee HJ; Kim JM; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
J Dermatol; 2017 Oct; 44(10):1190-1191. PubMed ID: 27790743
[No Abstract] [Full Text] [Related]
18. The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma.
Hashimoto S; Kuroha T; Yano T; Sato N; Furukawa T
Intern Med; 2016; 55(20):3025-3028. PubMed ID: 27746443
[TBL] [Abstract][Full Text] [Related]
19. [Necrobiotic xanthogranuloma. Differential diagnosis, treatment and systemic involvement. Case report].
Sanz-Marco E; España E; López-Prats MJ; Chirivella-Casanova M; Aviño J; Díaz-Llopis M
Arch Soc Esp Oftalmol; 2014 May; 89(5):186-9. PubMed ID: 24269389
[TBL] [Abstract][Full Text] [Related]
20. An unusual histologic variant of necrobiotic xanthogranuloma.
Ziemer M; Norgauer J; Simon JC; Koehler MJ
Am J Dermatopathol; 2012 Apr; 34(2):e22-6. PubMed ID: 22441374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
